Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?
- 1 August 2015
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 182, 64-69
Abstract
No abstract availableKeywords
Funding Information
- CNPq (443526/2014-1 and 470326/2011-5)
- Pesquisa (304443/2014-0)
- FAPERGS/CNPq (PRONEM 11/2057-2)
- CAPES (Ciências Sem Fronteiras)
- Scope Global
- NHMRC (1059660)
This publication has 66 references indexed in Scilit:
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel DiseaseNew England Journal of Medicine, 2013
- Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeresTranslational Psychiatry, 2013
- How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathwaysBrain and Behavior, 2013
- Pathology of asthmaFrontiers in Microbiology, 2013
- The role of BDNF in the pathophysiology and treatment of schizophreniaJournal of Psychiatric Research, 2012
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- Immune system to brain signaling: Neuropsychopharmacological implicationsPharmacology & Therapeutics, 2011
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- The genetics of bipolar disorderNeuroscience, 2009
- Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodesNeuroscience Letters, 2006